Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration

Description

During the typical SCS trial the leads remain outside of the skin and can be prone to migration. The leads are typically secured in place with suture, tape, or a combination of both. This study will evaluate the amount of movement based on the method of being secured at the time of placement

Conditions

Chronic Pain

Talk to us

Study Overview

On this page

Study Details

Study overview

During the typical SCS trial the leads remain outside of the skin and can be prone to migration. The leads are typically secured in place with suture, tape, or a combination of both. This study will evaluate the amount of movement based on the method of being secured at the time of placement

Use of Dermabond in Mitigation of Spinal Cord Stimulation Trial Lead Migration

Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration

Condition
Chronic Pain
Intervention / Treatment

-

Contacts and Locations

Winston-Salem

Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States, 27157

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * age greater than 18
  • * having a spinal cord stimulator trial lead placement done
  • * lead placement to be done in the thoracic spine area
  • * dermabond allergy
  • * inability to place 2 leads in subject
  • * lead placement not in thoracic spine

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Wake Forest University Health Sciences,

Carlyle Hamsher, MD, PRINCIPAL_INVESTIGATOR, Wake Forest University Health Sciences

Study Record Dates

2025-08